Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.

Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C.

Anesth Analg. 2018 May 31. doi: 10.1213/ANE.0000000000003563. [Epub ahead of print]

PMID:
29863609
2.

Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.

Burstein O, Shoshan N, Doron R, Akirav I.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):129-139. doi: 10.1016/j.pnpbp.2018.01.026. Epub 2018 Feb 17.

PMID:
29458190
3.

The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents.

Griebel G, Stemmelin J, Lopez-Grancha M, Fauchey V, Slowinski F, Pichat P, Dargazanli G, Abouabdellah A, Cohen C, Bergis OE.

Sci Rep. 2018 Feb 5;8(1):2416. doi: 10.1038/s41598-018-20895-z.

4.

Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents.

Duan T, Gu N, Wang Y, Wang F, Zhu J, Fang Y, Shen Y, Han J, Zhang X.

J Psychiatry Neurosci. 2017 Jun;42(4):230-241.

5.

FAAH inhibition produces antidepressant-like efforts of mice to acute stress via synaptic long-term depression.

Wang Y, Zhang X.

Behav Brain Res. 2017 May 1;324:138-145. doi: 10.1016/j.bbr.2017.01.054. Epub 2017 Feb 11.

PMID:
28193523
6.

Fatty acid amide hydrolase-morphine interaction influences ventilatory response to hypercapnia and postoperative opioid outcomes in children.

Chidambaran V, Pilipenko V, Spruance K, Venkatasubramanian R, Niu J, Fukuda T, Mizuno T, Zhang K, Kaufman K, Vinks AA, Martin LJ, Sadhasivam S.

Pharmacogenomics. 2017 Jan;18(2):143-156. doi: 10.2217/pgs-2016-0147. Epub 2016 Dec 15.

7.

A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats.

Kirkedal C, Wegener G, Moreira F, Joca SRL, Liebenberg N.

Acta Neuropsychiatr. 2017 Dec;29(6):324-329. doi: 10.1017/neu.2016.68. Epub 2016 Dec 12.

PMID:
27938441
8.

Characterisation of peroxisome proliferator-activated receptor signalling in the midbrain periaqueductal grey of rats genetically prone to heightened stress, negative affect and hyperalgesia.

Okine BN, Gaspar JC, Madasu MK, Olango WM, Harhen B, Roche M, Finn DP.

Brain Res. 2017 Feb 15;1657:185-192. doi: 10.1016/j.brainres.2016.11.022. Epub 2016 Dec 1.

PMID:
27916440
9.

Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors.

Simonnet A, Zamberletti E, Cador M, Rubino T, Caillé S.

Neuropharmacology. 2017 Feb;113(Pt A):252-259. doi: 10.1016/j.neuropharm.2016.10.007. Epub 2016 Oct 11.

PMID:
27737788
10.

The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings.

Berardi A, Schelling G, Campolongo P.

Pharmacol Res. 2016 Sep;111:668-678. doi: 10.1016/j.phrs.2016.07.024. Epub 2016 Jul 22. Review.

PMID:
27456243
11.

Pharmacological inhibition of FAAH activity in rodents: A promising pharmacological approach for psychological-cardiac comorbidity?

Carnevali L, Rivara S, Nalivaiko E, Thayer JF, Vacondio F, Mor M, Sgoifo A.

Neurosci Biobehav Rev. 2017 Mar;74(Pt B):444-452. doi: 10.1016/j.neubiorev.2016.04.013. Epub 2016 Apr 27. Review.

PMID:
27131970
12.

Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study.

Maple KE, McDaniel KA, Shollenbarger SG, Lisdahl KM.

Am J Drug Alcohol Abuse. 2016 Jul;42(4):431-40. doi: 10.3109/00952990.2016.1141913. Epub 2016 Apr 13.

13.

Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma.

Lazary J, Eszlari N, Juhasz G, Bagdy G.

Eur Neuropsychopharmacol. 2016 Jun;26(6):1020-8. doi: 10.1016/j.euroneuro.2016.03.003. Epub 2016 Mar 9.

14.
15.

Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats.

Carnevali L, Vacondio F, Rossi S, Callegari S, Macchi E, Spadoni G, Bedini A, Rivara S, Mor M, Sgoifo A.

Eur Neuropsychopharmacol. 2015 Nov;25(11):2157-69. doi: 10.1016/j.euroneuro.2015.07.015. Epub 2015 Jul 29.

PMID:
26391492
16.

Poorer frontolimbic white matter integrity is associated with chronic cannabis use, FAAH genotype, and increased depressive and apathy symptoms in adolescents and young adults.

Shollenbarger SG, Price J, Wieser J, Lisdahl K.

Neuroimage Clin. 2015 Apr 2;8:117-25. doi: 10.1016/j.nicl.2015.03.024. eCollection 2015.

17.

Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects.

Sadhasivam S, Zhang X, Chidambaran V, Mavi J, Pilipenko V, Mersha TB, Meller J, Kaufman KM, Martin LJ, McAuliffe J.

Pharmacogenomics J. 2015 Oct;15(5):436-42. doi: 10.1038/tpj.2014.79. Epub 2015 Jan 6.

18.

Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.

Wiebelhaus JM, Grim TW, Owens RA, Lazenka MF, Sim-Selley LJ, Abdullah RA, Niphakis MJ, Vann RE, Cravatt BF, Wiley JL, Negus SS, Lichtman AH.

J Pharmacol Exp Ther. 2015 Feb;352(2):195-207. doi: 10.1124/jpet.114.218677. Epub 2014 Nov 14.

19.

Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.

Lomazzo E, Bindila L, Remmers F, Lerner R, Schwitter C, Hoheisel U, Lutz B.

Neuropsychopharmacology. 2015 Jan;40(2):488-501. doi: 10.1038/npp.2014.198. Epub 2014 Aug 6.

20.

Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain.

Marco EM, Echeverry-Alzate V, López-Moreno JA, Giné E, Peñasco S, Viveros MP.

Behav Pharmacol. 2014 Sep;25(5-6):547-56. doi: 10.1097/FBP.0000000000000068.

PMID:
25083571

Supplemental Content

Loading ...
Support Center